WVE-N531

· Wave Life Sciences Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for WVE-N531, covering 2025-12-15 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy [Phase 2]